Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin
BACKGROUND: At Sunnybrook Health Sciences Centre in Toronto, Ontario, the recommended empiric regimen for febrile neutropenia has been cefazolin and tobramycin for at least 25 years. However, we had no objective data to reassure us that patient mortality had not increased over the past five years.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2009/631969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555059167100928 |
|---|---|
| author | Francesca Le Piane Sandra AN Walker Scott E Walker Nina Lathia Carlo De Angelis Andrew Simor |
| author_facet | Francesca Le Piane Sandra AN Walker Scott E Walker Nina Lathia Carlo De Angelis Andrew Simor |
| author_sort | Francesca Le Piane |
| collection | DOAJ |
| description | BACKGROUND: At Sunnybrook Health Sciences Centre in Toronto, Ontario, the recommended empiric regimen for febrile neutropenia has been cefazolin and tobramycin for at least 25 years. However, we had no objective data to reassure us that patient mortality had not increased over the past five years. |
| format | Article |
| id | doaj-art-9262388039d94fd387d7e047fa2c0539 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-9262388039d94fd387d7e047fa2c05392025-02-03T05:49:47ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322009-01-01204e145e15210.1155/2009/631969Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and TobramycinFrancesca Le Piane0Sandra AN Walker1Scott E Walker2Nina Lathia3Carlo De Angelis4Andrew Simor5Department of Pharmacy, Sunnybrook Health Sciences Centre, CanadaDepartment of Pharmacy, Sunnybrook Health Sciences Centre, CanadaDepartment of Pharmacy, Sunnybrook Health Sciences Centre, CanadaDepartment of Pharmacy, Sunnybrook Health Sciences Centre, CanadaDepartment of Pharmacy, Sunnybrook Health Sciences Centre, CanadaDivision of Infectious Diseases, Sunnybrook Health Sciences Centre, CanadaBACKGROUND: At Sunnybrook Health Sciences Centre in Toronto, Ontario, the recommended empiric regimen for febrile neutropenia has been cefazolin and tobramycin for at least 25 years. However, we had no objective data to reassure us that patient mortality had not increased over the past five years.http://dx.doi.org/10.1155/2009/631969 |
| spellingShingle | Francesca Le Piane Sandra AN Walker Scott E Walker Nina Lathia Carlo De Angelis Andrew Simor Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin |
| title_full | Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin |
| title_fullStr | Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin |
| title_full_unstemmed | Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin |
| title_short | Mortality in a Heterogeneous Population of Low-Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin |
| title_sort | mortality in a heterogeneous population of low risk febrile neutropenic patients treated initially with cefazolin and tobramycin |
| url | http://dx.doi.org/10.1155/2009/631969 |
| work_keys_str_mv | AT francescalepiane mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin AT sandraanwalker mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin AT scottewalker mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin AT ninalathia mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin AT carlodeangelis mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin AT andrewsimor mortalityinaheterogeneouspopulationoflowriskfebrileneutropenicpatientstreatedinitiallywithcefazolinandtobramycin |